Skip to content

THOMAS BROOS

Active
Private limited companyfounded 201016 yrs activeTermerestraat 2, 3020 Herent, BelgiumKBO/BCE: BE 0822.320.765
Summary

THOMAS BROOS has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €560k and a net result of €90k. Equity is growing by ~3% per year across the filed fiscal years. Its solvency ranks better than 61% of 10407 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability67▲+10
Solvency72▼-4
Growth52=
Track record100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity short (current ratio 0.14 against 0.17 in 2024; short-term debt: 44.4% and cash: 3.8% of total assets), and 52.8% of the assets are financed with debt.
Credit check for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
47.2%
Return on assets
7.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 16 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-03-2026, 130 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
130 d early
2024
153 d early
2023
153 d early
2022
133 d early
2021
59 d early
2020
9 d early
2019
28 d late
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
25-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Source amounts without an identifiable currency are assumed to be EUR.

Equity
€560k▼ 6.7%
2024 · €600k
2018: €494klowest in 8 years 2019: €502k▲ +1.6% vs 2018 2020: €582k▲ +16.1% vs 2019 2021: €542k▼ -6.9% vs 2020 2022: €555k▲ +2.3% vs 2021 2023: €577k▲ +4.0% vs 2022 2024: €600k▲ +4.0% vs 2023highest in 8 years 2025: €560k▼ -6.7% vs 2024
2018 → 2025
Total assets
€1.19M▲ 0.9%
2024 · €1.18M
2018: €1.21Mhighest in 8 years 2019: €1.21M● -0.0% vs 2018 2020: €1.17M▼ -3.4% vs 2019 2021: €1.15M▼ -2.1% vs 2020lowest in 8 years 2022: €1.15M▲ +0.4% vs 2021 2023: €1.15M▼ -0.4% vs 2022 2024: €1.18M▲ +2.3% vs 2023 2025: €1.19M▲ +0.9% vs 2024
2018 → 2025
Net result
€90k▼ 0.6%
2024 · €91k
2018: €102k 2019: €75k▼ -26.8% vs 2018lowest in 8 years 2020: €131k▲ +75.2% vs 2019highest in 8 years 2021: €84k▼ -35.6% vs 2020 2022: €114k▲ +36.1% vs 2021 2023: €97k▼ -15.6% vs 2022 2024: €91k▼ -5.8% vs 2023 2025: €90k▼ -0.6% vs 2024
2018 → 2025
Working capital
€-455k▼ 36.1%
2024 · €-334k
2018: €6khighest in 8 years 2019: €-99k▼ -1858% vs 2018 2020: €-99k● -0.0% vs 2019 2021: €-198k▼ -101% vs 2020 2022: €-250k▼ -26.4% vs 2021 2023: €-293k▼ -17.4% vs 2022 2024: €-334k▼ -13.9% vs 2023 2025: €-455k▼ -36.1% vs 2024lowest in 8 years
2018 → 2025
Trend over the years
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€542k-€555k▲ 2.3%€577k▲ 4.0%€600k▲ 4.0%€560k▼ 6.7% 2021: €542klowest in 5 years 2022: €555k▲ +2.3% vs 2021 2023: €577k▲ +4.0% vs 2022 2024: €600k▲ +4.0% vs 2023highest in 5 years 2025: €560k▼ -6.7% vs 2024
Operating result€108k-€113k▲ 4.9%€104k▼ 8.3%€122k▲ 17.5%€119k▼ 2.2% 2021: €108k 2022: €113k▲ +4.9% vs 2021 2023: €104k▼ -8.3% vs 2022lowest in 5 years 2024: €122k▲ +17.5% vs 2023highest in 5 years 2025: €119k▼ -2.2% vs 2024
Net result€84k-€114k▲ 36.1%€97k▼ 15.6%€91k▼ 5.8%€90k▼ 0.6% 2021: €84klowest in 5 years 2022: €114k▲ +36.1% vs 2021highest in 5 years 2023: €97k▼ -15.6% vs 2022 2024: €91k▼ -5.8% vs 2023 2025: €90k▼ -0.6% vs 2024
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100kOperating result 2021: €108k€108kNet result 2021: €84k€84kOperating result 2022: €113k€113kNet result 2022: €114k€114kOperating result 2023: €104k€104kNet result 2023: €97k€97kOperating result 2024: €122k€122kNet result 2024: €91k€91kOperating result 2025: €119k€119kNet result 2025: €90k€90k20212022202320242025€0€50k€100kOperating result 2023: €104k€104kNet result 2023: €97k€97kOperating result 2024: €122k€122kNet result 2024: €91k€91kOperating result 2025: €119k€119kNet result 2025: €90k€90k202320242025
The operating result falls in 2025; 2025 is 2% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.19M
Fixed assets €1.11M ▲ 0.7%
Current assets €72k ▲ 3.5%
Equity and liabilities €1.19M
Equity €560k ▼ 6.7%
Debt €627k ▲ 8.8%
Debt's share of the balance-sheet total rises from 49.0% to 52.8%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€120k
Cash flow
€92k
Current ratio
0.14▼
2024 · 0.17
Debt to equity
1.12▲
2024 · 0.96
ROE
16.2%▲
2024 · 15.2%
ROA
7.6%▼
2024 · 7.7%
Interest coverage
4.68
Debt ≤ 1 year
€526k▲
2024 · €403k
Debt > 1 year
€85k▼
2024 · €158k
Income taxes
€28k▼
2024 · €28k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 46 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.18M€1.19M▲
Fixed assets21/28€1.11M€1.11M▲
Tangible fixed assets22/27-€8k
Plant, machinery and equipment23-€3k
Furniture and vehicles24-€5k
Financial fixed assets28€1.11M€1.11M=
Current assets29/58€69k€72k▲
Amounts receivable within one year40/41€33k€25k▼
Trade receivables40€33k€25k▼
Other amounts receivable41€15-
Cash at bank and in hand54/58€35k€46k▲
Deferred charges and accrued income490/1€2k€918▼
Equity and liabilities
Total equity and liabilities10/49€1.18M€1.19M▲
Equity10/15€600k€560k▼
Contributions10/11€12k€12k=
Reserves13€588k€547k▼
Distributable reserves133€588k€547k▼
Amounts payable17/49€576k€627k▲
Amounts payable after more than one year17€158k€85k▼
Financial debts170/4€158k€85k▼
Amounts payable within one year42/48€403k€526k▲
Current portion of amounts payable after more than one year42€70k€72k▲
Trade debts44€10k€12k▲
Suppliers440/4€10k€12k▲
Taxes, remuneration and social security45€22k€25k▲
Taxes450/3€22k€25k▲
Other amounts payable47/48€301k€417k▲
Accrued charges and deferred income492/3€15k€15k▲
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€1k
Other operating charges640/8€1k€1k▲
Gross operating margin9900€123k€121k▼
Operating profit (loss)9901€122k€119k▼
Financial income75/76B€25k€25k=
Recurring financial income75€25k€25k=
Financial charges65/66B€28k€26k▼
Recurring financial charges65€28k€26k▼
Profit (loss) for the period before taxes9903€119k€118k▼
Income taxes67/77€28k€28k▼
Profit (loss) for the period9904€91k€90k▼
Profit (loss) for the period to be appropriated9905€91k€90k▼
Appropriation of the result
Profit (loss) to be appropriated9906€91k€90k▼
Transfer from equity791/2€68k€131k▲
Transfer to equity691/2€91k€90k▼
To other reserves6921€91k€90k▼
Profit to be distributed694/7€68k€131k▲
Return on contributions (dividend)694€68k€131k▲

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Accounts by statement
Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2k---€1k-
Other operating charges640/8€941€944€1k€1k€1k▲ 3.2%
Gross operating margin9900€110k€114k€105k€123k€121k▼ 1.1%
Operating profit (loss)9901€108k€113k€104k€122k€119k▼ 2.2%
Financial income75/76B€20k€50k€40k€25k€25k=
Recurring financial income75€20k€50k€40k€25k€25k=
Financial charges65/66B€17k€18k€20k€28k€26k▼ 6.9%
Recurring financial charges65€17k€18k€20k€28k€26k▼ 6.9%
Profit (loss) for the period before taxes9903€111k€145k€123k€119k€118k▼ 0.6%
Income taxes67/77€27k€31k€27k€28k€28k▼ 0.8%
Profit (loss) for the period9904€84k€114k€97k€91k€90k▼ 0.6%
Profit (loss) for the period to be appropriated9905€84k€114k€97k€91k€90k▼ 0.6%
Line20212022202320242025Change
Assets
Total assets20/58€1.15M€1.15M€1.15M€1.18M€1.19M▲ 0.9%
Fixed assets21/28€1.11M€1.11M€1.11M€1.11M€1.11M▲ 0.7%
Tangible fixed assets22/27----€8k-
Plant, machinery and equipment23----€3k-
Furniture and vehicles24----€5k-
Financial fixed assets28€1.11M€1.11M€1.11M€1.11M€1.11M=
Current assets29/58€41k€46k€42k€69k€72k▲ 3.5%
Amounts receivable within one year40/41€17k€23k€24k€33k€25k▼ 23.7%
Trade receivables40€17k€23k€24k€33k€25k▼ 23.6%
Other amounts receivable41---€15--
Cash at bank and in hand54/58€24k€22k€17k€35k€46k▲ 31.9%
Deferred charges and accrued income490/1€581€2k€2k€2k€918▼ 47.2%
Equity and liabilities
Total equity and liabilities10/49€1.15M€1.15M€1.15M€1.18M€1.19M▲ 0.9%
Equity10/15€542k€555k€577k€600k€560k▼ 6.7%
Contributions10/11€12k€12k€12k€12k€12k=
Reserves13€530k€542k€564k€588k€547k▼ 6.8%
Non-distributable reserves130/1€2k€2k----
Reserves not available under the articles1311€2k€2k----
Distributable reserves133€528k€540k€564k€588k€547k▼ 6.8%
Amounts payable17/49€606k€599k€573k€576k€627k▲ 8.8%
Amounts payable after more than one year17€364k€297k€228k€158k€85k▼ 45.9%
Financial debts170/4€364k€297k€228k€158k€85k▼ 45.9%
Amounts payable within one year42/48€239k€296k€336k€403k€526k▲ 30.5%
Current portion of amounts payable after more than one year42€64k€67k€69k€70k€72k▲ 2.9%
Trade debts44€7k€10k€14k€10k€12k▲ 21.5%
Suppliers440/4€7k€10k€14k€10k€12k▲ 21.5%
Taxes, remuneration and social security45€17k€21k€17k€22k€25k▲ 12.8%
Taxes450/3€17k€21k€17k€22k€25k▲ 12.8%
Other amounts payable47/48€151k€199k€236k€301k€417k▲ 38.6%
Accrued charges and deferred income492/3€3k€5k€9k€15k€15k▲ 0.2%
Line20212022202320242025Change
Profit (loss) for the period9904€84k€114k€97k€91k€90k▼ 0.6%
+ Depreciation and write-downs630€2k---€1k-
Operating cash flow (approximation)€86k€114k€97k€91k€92k▲ 0.8%
Investment in fixed assets (approximation)-€0€0€0€-9k-
Change in cash-€-2k€-5k€18k€11k▼ 38.3%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Sign in to download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
23-03
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
28-02
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-02
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
20-03
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
02-06
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
22-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Highest result since 2018net €131k ▲75.2%
Net result €131k, the highest in the series.
28-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
31-12
Financial Weakest financial yearnet €75k ▼26.8%
Net result drops to €75k, the lowest in the series; recovery starts the following year.
31-12
Financial Equity above €500kEq €502k ▲1.6%
2 profitable years in a row build equity to €502k.
30-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
25-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
20-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts

We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Herent · 1 establishment unit since 2010
seat establishment The establishment unit on the map
Ground area
5,926 m²
Building footprint
414 m²
Volume, LiDAR
1,534 m³
2 parcels, Flanders · tallest building 8.0 m, ±2 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
THOMAS BROOS
Heidestraat 15, 3020 HerentRetail sale of pharmaceutical products
since 20102.184.115.643
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24127C0028/00V000 Flanders 4,109 m² 1 · 170 m² 7.6 m · 1 fl.
24127C0048/00Z002 Flanders 1,817 m² 1 · 244 m² 8.0 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,861. 3,313 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded14-01-2010
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
47750Retail sale of cosmetics and toilet articles

Scores and ratios are computed by Checked and are not a credit decision.